Compare Jantra Grupo Indonesia Tbk. (KAQI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jantra Grupo Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Jantra Grupo Indonesia Tbk. trades at Rp98 (market cap 201.35B, 38.62M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jantra Grupo Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| KAQI | SCPI | |
|---|---|---|
Market Cap | 201.35B | 104.4B |
Volume | 38.62M | — |
Lot | 386.24K | — |
Turnover | 3.75B | — |
Average Price | 97.02 | — |
Value | 3.75B | — |
Indicative Equilibrium Price | 98 | — |
Indicative Equilibrium Volume | 16.32K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jantra Grupo Indonesia Tbk.
PT Jantra Grupo Indonesia Tbk (Company) was established on 26 September 2017 based on a Deed Notary No. 102 was made by Suhardi Hadi Santoso, S.H., Notary in Jakarta.
Read more on KAQI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
